Blood Cancers Today | February 2023 Issue | Blood Cancers Today

February 2023

This issue of Blood Cancers Today features a Get to Know with Chadi Nabhan, MD, MBA, FACP, who is the podcast host of The HemOnc Pulse; a debate on whether CAR-T or bispecific antibodies are best for patients with multiple myeloma; a feature on treatment options after CAR-T failure in B-cell lymphoma; and more.

Viewpoints

Associate Editor's Message

How to Choose the Right Treatment When There Are So Many Options in DLBCL

Features

Point | Counterpoint

CAR-T Versus Bispecific Antibodies in Multiple Myeloma: Which Is the Better Option for Patients?

In Focus

An Unclear Path: What’s the Best Route After CAR-T Failure in B-Cell Lymphoma?

Get to Know

Get to Know ... Chadi Nabhan, MD, MBA, FACP

News

In the Literature

Protein Expression Signatures May Be Prognostic in Pediatric AML

TP53 Mutations Linked with Lenalidomide in Therapy-Related Myeloid Neoplasms

Regulatory Actions

FDA Grants Priority Review to Bispecific Antibody Glofitamab for Relapsed or Refractory LBCL

FDA Approves Zanubrutinib for CLL, SLL

FDA Receives BLA for Talquetamab in Relapsed/Refractory Multiple Myeloma

Moxetumomab Pasudotox for Hairy Cell Leukemia to Be Withdrawn From US Market

News Roundup

Post-AHSCT Brentuximab Vedotin Plus Nivolumab ‘Highly Active’ in Hodgkin Lymphoma

Better Outcomes with Active Therapy in MDS

State of the Art

The Role of AML Maintenance Therapy

February 2023

Advertisement

Advertisement

Editorial Board

Sagar Lonial, MD, FACPEditor-in-Chief | Chief Medical Officer of Winship Cancer Institute at Emory University School of Medicine

Thomas Martin, MDAssociate Editor | Clinical Research Director, UCSF Helen Diller Family Comprehensive Cancer Center

Laurie Sehn, MD, MPHAssociate Editor | Clinical Professor of Medical Oncology, British Columbia Cancer Centre for Lymphoid Cancer

Elias Jabbour, MDExecutive Editor | DB Lane Cancer Research Fund Distinguished Professor in Leukemia Research, MD Anderson Cancer Center

Jerald Radich, MDAssociate Editor | Professor in the Clinical Research Division and Kurt Enslein Endowed Chair at Fred Hutch